Integra Lifesciences Holdings Corp (IART)

45.15
1.40 3.20
NASDAQ : Health Care
Prev Close 43.74
Open 42.50
Day Low/High 41.67 / 45.36
52 Wk Low/High 54.75 / 81.82
Volume 597.71K
Avg Volume 647.20K
Exchange NASDAQ
Shares Outstanding 75.26M
Market Cap 3.23B
EPS 1.00
P/E Ratio 45.62
Div & Yield N.A. (N.A)

Latest News

Integra LifeSciences Announces Expansion Of Credit Facility To Include New $700 Million Term Loan

Integra LifeSciences Announces Expansion Of Credit Facility To Include New $700 Million Term Loan

Financing now secured for the planned acquisition of Codman Neurosurgery

Dr. Reddy's And Integra LifeSciences Enter Into An Agreement To Market And Distribute DuraGen Plus® And Suturable DuraGen® Dural Regeneration In India

Dr. Reddy's And Integra LifeSciences Enter Into An Agreement To Market And Distribute DuraGen Plus® And Suturable DuraGen® Dural Regeneration In India

Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that they have entered into an...

Integra LifeSciences Reports Fourth Quarter And Full-Year 2016 Financial Results And Updates 2017 Full-Year Guidance

Integra LifeSciences Reports Fourth Quarter And Full-Year 2016 Financial Results And Updates 2017 Full-Year Guidance

2016 Results and 2017 Guidance in line with January 10, 2017 Preliminary Announcement

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra hopes this deal will grow its revenue to $2 billion sooner than expected.

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

The company hopes the JNJ assets will give revenue growth a boost.

Derma Sciences Soars Almost 40% on Buyout by Integra

Derma Sciences Soars Almost 40% on Buyout by Integra

The company's shares hit $6.95 Wednesday midday.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DLR, ESXB, IART, NMR, PBIB, PLNT, SANW, TCK Downgrades: AAN, ABMD, AXTA, CMC, CMPR, CVI, CVRR, DSPG, EHTH, ESSA, FCFS, NPTN, NWS, UHT, VDSI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Analysts' Actions -- AES, CBOE, Las Vegas Sands, PacWest Bancorp and More

Analysts' Actions -- AES, CBOE, Las Vegas Sands, PacWest Bancorp and More

Here are Tuesday's top research calls, including upgrades for CBOE and Las Vegas Sands, and downgrades for AES and PacWest Bancorp.